MARKET

MRNA

MRNA

Moderna
NASDAQ
24.02
-1.47
-5.77%
After Hours: 24.20 +0.18 +0.75% 19:57 05/14 EDT
OPEN
25.54
PREV CLOSE
25.49
HIGH
25.58
LOW
23.95
VOLUME
12.81M
TURNOVER
--
52 WEEK HIGH
170.47
52 WEEK LOW
23.15
MARKET CAP
9.29B
P/E (TTM)
-2.7585
1D
5D
1M
3M
1Y
5Y
1D
Stocks Settle Mixed on Chip Stock Strength and Higher Bond Yields
NASDAQ · 5h ago
Moderna Inc. Stock Slides 5.8%, Underperforms Competitors
Dow Jones · 6h ago
Wednesday Sector Laggards: Healthcare, Materials
NASDAQ · 8h ago
Alnylam drops Covid vaccine patent case against Pfizer, BioNTech for now
Reuters · 10h ago
Bernstein Sticks to Their Hold Rating for Moderna (MRNA)
TipRanks · 18h ago
Moderna Faces Revenue Challenges Amid Disappointing RSV Vaccine Launch and Limited Near-Term Growth Prospects
TipRanks · 20h ago
S&P 500 turns positive for 2025; here are its best and worst YTD performers
Seeking Alpha · 1d ago
MRNA Quantitative Stock Analysis - Benjamin Graham
NASDAQ · 1d ago
More
About MRNA
More
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
Recently
Symbol
Price
%Change

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.